Drug · DIN 02482207
KUVAN
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since December 5, 2019; first marketed December 5, 2019.
- Drug Identification Number (DIN)
- 02482207
- Company (DIN owner)
- Biomarin International LimitedRingaskiddy, Cork, Ireland
- Schedule
- Prescription
- Dosage form
- Powder
- Route
- Oral
- Therapeutic class (ATC)
- Sapropterin A16AX07
- Class
- Human
- Record last updated
- July 10, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| SAPROPTERIN DIHYDROCHLORIDE | 100 MG | SACHET |
Notices of Compliance
Health Canada approvals that name this DIN.
- March 14, 2019: NOC 21973New Drug Submission (NDS) · Manufacturer name change
- November 8, 2018: NOC 21507Supplement to a New Drug Submission (SNDS) · New Form: Powder
Other DINs named KUVAN
- DIN 02350580 · Marketed
- DIN 02482215 · Cancelled Post Market